Curaleaf Holdings Inc
TSX:CURA
Curaleaf Holdings Inc
TSX:CURA
Price:
3.31
CAD
2.16%
Market Closed
Market Cap:
CA$2.6B
Relative Value
The Relative Value of one
CURA
stock under the Base Case scenario is
4.56
CAD.
Compared to the current market price of 3.31 CAD,
Curaleaf Holdings Inc
is
Undervalued by 27%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CURA
Relative Value
Base Case
4.56
CAD
Undervaluation 27%
Multiples Across Competitors
CURA Competitors Multiples
Curaleaf Holdings Inc Competitors
Curaleaf Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Curaleaf Holdings Inc
TSX:CURA
|
2.5B CAD | 1.5 | -7.5 | 10.5 | 443.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD | 15.1 | 47.7 | 32.1 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.2B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.9B CHF | 4.7 | 30.8 | 13 | 15.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233.3B GBP | 5.5 | 31.5 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
241.3B CHF | 5.6 | 22.5 | 13.9 | 17.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.5 | 9.8 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.3B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
